3SBio Inc. (HKG:1530)
Hong Kong · Delayed Price · Currency is HKD 14.44
-0.32 (-2.17%)
Oct 14, 2026, 4:08 PM HKT
3SBio Market Cap
3SBio has a market cap or net worth of 35.99 billion as of October 14, 2026. It is the 3,886th most valuable company in the world and the 195th biggest in Hong Kong. Its market cap has decreased by 45.93% in one year.
Market Cap
35.99B
Enterprise Value
21.18B
Revenue
20.63B
Global Rank
Country Rank
#195 Hong Kong
PE Ratio
3.85
ChartMarket Cap Chart
Since June 11, 2015, 3SBio's market cap has increased from 22.67B to 35.99B, an increase of 58.76%. That is a compound annual growth rate of 4.16%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 14, 2026 | 35.99B | -40.41% |
| Dec 31, 2025 | 60.39B | 321.75% |
| Dec 31, 2024 | 14.32B | -20.61% |
| Dec 29, 2023 | 18.04B | -10.89% |
| Dec 30, 2022 | 20.24B | 23.46% |
| Dec 31, 2021 | 16.40B | -8.83% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Genscript Biotech | 96.10B |
| RemeGen | 59.77B |
| Biocytogen Pharmaceuticals (Beijing) | 43.97B |
| Shanghai Junshi Biosciences | 33.75B |
| Shanghai Henlius Biotech | 28.60B |
| InSilico Medicine Cayman TopCo | 27.25B |
| InnoCare Pharma | 26.61B |
| Keymed Biosciences | 23.54B |